Celtaxsys Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
10
- Latest Deal Type
-
Out of Business
Celtaxsys General Information
Description
Developer of a novel therapeutics designed to treat inflammatory disease through regulation of immune cell migration and activation. The company is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases, enabling patients to be treated with rare and serious inflammatory conditions.
Contact Information
Website
www.celtaxsys.comCorporate Office
- 201 17th Street
- Suite 530
- Atlanta, GA 30363
- United States
Corporate Office
- 201 17th Street
- Suite 530
- Atlanta, GA 30363
- United States
Celtaxsys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 22-Oct-2020 | Completed | Out of Business | |||
| 6. Later Stage VC (Series E) | 18-Dec-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 08-Jun-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 27-Oct-2010 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 07-May-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 14-May-2008 | $3.7M | $8.9M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 22-Jul-2005 | $5.19M | $5.19M | Completed | Startup |
Celtaxsys Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D |
Celtaxsys Comparisons
Industry
Financing
Details
Celtaxsys Competitors (22)
One of Celtaxsys’s 22 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| XBiotech | Corporation | Austin, TX | ||||
| Toleranzia | Private Equity-Backed | Gothenburg, Sweden | ||||
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | ||||
| Corbus Pharmaceuticals Holdings | Formerly VC-backed | Norwood, MA |
Celtaxsys Patents
Celtaxsys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10898484-B2 | Method of reducing pulmonary exacerbations in respiratory disease patients | Active | 31-May-2018 | ||
| US-20190365750-A1 | Method of reducing pulmonary exacerbations in respiratory disease patients | Active | 31-May-2018 | ||
| WO-2019232306-A1 | Method of reducing pulmonary exacerbations in respiratory disease patients | Inactive | 31-May-2018 | ||
| US-20190161471-A1 | Inhibitors of leukotriene a4 hydrolase | Inactive | 09-Dec-2016 | ||
| WO-2018107153-A1 | Inhibitors of leukotriene a4 hydrolase | Inactive | 09-Dec-2016 | C07D401/06 |
Celtaxsys Signals
Celtaxsys FAQs
-
When was Celtaxsys founded?
Celtaxsys was founded in 2004.
-
Where is Celtaxsys headquartered?
Celtaxsys is headquartered in Atlanta, GA.
-
What is the size of Celtaxsys?
Celtaxsys has 10 total employees.
-
What industry is Celtaxsys in?
Celtaxsys’s primary industry is Drug Discovery.
-
Is Celtaxsys a private or public company?
Celtaxsys is a Private company.
-
What is Celtaxsys’s current revenue?
The current revenue for Celtaxsys is .
-
How much funding has Celtaxsys raised over time?
Celtaxsys has raised $75.2M.
-
Who are Celtaxsys’s competitors?
AnTolRx, XBiotech, Toleranzia, Aclaris Therapeutics, and Corbus Pharmaceuticals Holdings are some of the 22 competitors of Celtaxsys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process